









Markets
/
Stocks
/
nasdaq-apus
/

Apimeds Pharmaceuticals US Inc

APUS

1.540USD

-0.230-12.99%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

19.37MMarket Cap

LossP/E TTM



Apimeds Pharmaceuticals US Inc

1.540

-0.230-12.99%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Apimeds Pharmaceuticals US Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-824.29%-1.73M

-1726.14%-3.36M

92.28%-20.31K

70.75%-99.62K

31.47%-186.75K

-3027.00%-184.06K

-2879.95%-263.10K

-1606.71%-340.57K

---272.50K

---5.89K

---8.83K

---19.95K

Net income from continuing operations

-435.68%-1.78M

-492.44%-2.66M

-35.73%-402.40K

45.03%-311.63K

-202.24%-332.52K

-1145.60%-449.36K

-358.71%-296.47K

-660.07%-566.97K

---110.02K

---36.08K

---64.63K

---74.59K

Operating gains losses

--1.49K

--232.00

----

Other non-cash items

-100.00%1.00

-4.13%13.06K

41.28%26.78K

390.27%24.85K

--22.53K

--13.62K

--18.95K

--5.07K

----

--0.00

----

Change in working capital

-84.55%17.48K

-1171.09%-2.60M

5395.87%355.31K

0.38%213.73K

166.32%113.13K

48639.92%243.19K

--6.46K

9984.63%212.91K

---170.57K

---501.00

--0.00

---2.15K

-Change in prepaid expenses

---431.01K

-178866000.00%-1.79M

-96.82%40.00

-99.54%734.00

100.00%0.00

--1.00

--1.26K

21798.36%160.08K

---171.67K

--0.00

--731.00

-Change in payables and accrued expense

296.45%448.49K

-435.57%-816.06K

6506.72%344.01K

231.64%175.23K

10184.36%113.13K

48639.72%243.18K

--5.21K

1931.47%52.84K

--1.10K

---501.00

--0.00

---2.88K

Cash from non-recurring investing activities

Cash from operating activities

-824.29%-1.73M

-1726.14%-3.36M

92.28%-20.31K

70.75%-99.62K

31.47%-186.75K

-3027.00%-184.06K

-2879.95%-263.10K

-1606.71%-340.57K

---272.50K

---5.89K

---8.83K

---19.95K

Investing cash flow

Net cash from continuing investing activities

--22.54K

--13.37K

----

Capital expenditures

--22.54K

--13.37K

----

Net cash flow from disposal of fixed assets

--22.54K

--13.37K

----

Cash from non-current investing activities

Net cash flow from investing activities

---22.54K

---13.37K

----

--0.00

----

--0.00

----

Financing cash flow

Cash flow from continuous financing activities

-100.00%0.00

11759.45%11.86M

--267.20K

--76.50K

-85.34%150.00K

--100.00K

-100.00%0.00

--1.02M

--0.00

--9.00K

--282.90K

Net cash flow from debt Issuance/repayment

-100.00%0.00

--250.00K

--0.00

--150.00K

--100.00K

----

--260.00K

Net cash flow from common stock issuance/repurchase

--0.00

--11.95M

----

--55.00K

--1.00M

----

Net cash flow from other financing activities

--0.00

---93.60K

--17.20K

239.09%76.50K

-100.00%0.00

--0.00

-100.00%0.00

-340.17%-55.00K

--23.10K

--0.00

--9.00K

--22.90K

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.00%0.00

11759.45%11.86M

--267.20K

--76.50K

-85.34%150.00K

--100.00K

-100.00%0.00

--1.02M

--0.00

--9.00K

--282.90K

Net cash flow

Beginning cash balance

13694.21%8.74M

69.86%250.34K

-99.16%3.46K

--26.57K

13787.28%63.33K

2223.89%147.38K

6551.77%410.48K

--0.00

--456.00

--6.34K

--6.17K

--0.00

Current period cash flow changes

-4657.74%-1.75M

10194.56%8.48M

193.84%246.89K

93.21%-23.12K

-104.90%-36.76K

-1328.05%-84.06K

-153959.65%-263.10K

-229.52%-340.57K

--750.60K

---5.89K

--171.00

--262.94K

Ending cash balance

26194.14%6.99M

13694.21%8.74M

69.86%250.34K

101.01%3.46K

-96.46%26.57K

13787.28%63.33K

2223.89%147.38K

-229.52%-340.57K

--751.05K

--456.00

--6.34K

--262.94K

Free cash flow

---1.75M

---3.37M

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

